Table 2.
Correlation between Per1 and Per2 expression and clinicopathological variables of the 246 gastric cancer cases
| Characteristics | Per1 | P-value | Per2 | P-valuea | ||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Low No. cases (%) | High No. cases (%) | Low No. cases (%) | High No. cases (%) | |||
| Gender | 0.144 | 1.000 | ||||
| Female | 43 (30.1) | 22 (21.4) | 42 (26.2) | 23 (26.7) | ||
| Male | 100 (69.9) | 81 (78.6) | 118 (73.8) | 63 (73.3) | ||
| Size (cm) | 0.789 | 0.784 | ||||
| ≤ 5.0 | 91 (63.6) | 63 (61.2) | 99 (68.9) | 55 (64.0) | ||
| > 5.0 | 52 (36.4) | 40 (38.8) | 61 (38.1) | 31 (36.0) | ||
| Age (years) | 0.897 | 0.789 | ||||
| ≤ 60 | 77 (53.8) | 54 (52.4) | 84 (52.5) | 47 (54.7) | ||
| > 60 | 66 (46.2) | 49 (47.6) | 76 (47.5) | 39 (45.3) | ||
| Location | 1.000 | 0.687 | ||||
| Upper | 63 (40.1) | 45 (43.7) | 72 (45.0) | 36 (41.9) | ||
| Middle/lower | 80 (59.9) | 58 (56.3) | 88 (55.0) | 50 (58.1) | ||
| Clinical Stage | < 0.001 | 0.021 | ||||
| I + II | 19 (13.3) | 44 (42.7) | 33 (20.6) | 30 (34.9) | ||
| III + IV | 124 (86.7) | 59 (57.3) | 127 (79.4) | 56 (65.1) | ||
| Depth of invasion | < 0.001 | 0.007 | ||||
| T1 + T2 | 14 (9.8) | 34 (33.0) | 23 (14.4) | 25 (29.1) | ||
| T3 + T4 | 129 (90.2) | 69 (67.0) | 137 (85.6) | 61 (70.9) | ||
| Lymph node metastasis | < 0.001 | 0.413 | ||||
| Negative | 19 (13.3) | 33 (32.0) | 31 (19.4) | 21 (24.4) | ||
| Positive | 124 (86.7) | 70 (68.0) | 129 (80.6) | 65 (75.6) | ||
| Pathologic differentiation | < 0.001 | 0.239 | ||||
| Well + Moderate differentiation adenocarcinoma | 22 (15.4) | 49 (47.6) | 42 (26.2) | 29 (33.7) | ||
| Poor differentiation adenocarcinoma | 121 (84.6) | 54 (52.4) | 118 (73.3) | 57 (66.3) | ||
a
p value < 0.05.